Year: 2021
Type: review
Source: Metabolic Brain Disease
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: non-coding RNA, disease mechanisms, chromatin remodeling, dosage compensation, genomic imprinting, splicing regulation, post-translational regulation, proteomics, Silver-Russell syndrome, facioscapulohumeral muscular dystrophy, cardiovascular disease, neurodegenerative diseases, spinal muscular atrophy, cancer, viral infection
Open Access status: bronze
Awards: Small Molecule Inhibitor Therapeutic Target for Alzheimer's Disease., MicroRNA-455-3p and Alzheimer's Disease, Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease, G3626104518, G5569935888, Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease, Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease, Mitochondrial Molecules as Therapeutic Drugs for Alzheimer's Disease, Small Molecules as Therapeutic Targets for Alzheimer's Disease
OpenAlex ID: W3153976197
